Development Programs

Kowa’s R&D activities are carried out at the company’s laboratories in Tokyo and Fuji. The focus is on lifestyle-related diseases, immune disorders and allergy, and dermatology and ophthalmology.

Kowa Research Institute is responsible for the U.S. development of Kowa’s new drug candidates.  For an overview of Kowa’s drug candidates currently in Phase I or later clinical development please click on the following link:

Copyright © 2018, Kowa Research Institute, Inc. All Rights Reserved.
Website designed and developed by
Polloni Design.